Great Point Partners’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q3
– Sell
-233
Closed -$1.57M – 34
2013
Q2
$1.57M Hold
233
– – 1.24% 21

Other funds holding GYRE

Great Point Partners's GYRE Position: Q3 2013 in Review

Great Point Partners sold out of Gyre Therapeutics (GYRE) in Q3 2013, closing a stake of 233 shares — an estimated $1.57M sold.

Great Point Partners first reported a position in GYRE in Q2 2013 and held it in 1 quarter. The position peaked at $1.57M in Q2 2013. 73 funds tracked by Wall St. Rank hold GYRE as of Q3 2013.

  • Great Point Partners reported no remaining Gyre Therapeutics position as of Q3 2013 after selling out during the quarter.
  • Great Point Partners sold 233 Gyre Therapeutics shares in Q3 2013, an estimated $1.57M.
  • Great Point Partners first reported a position in Gyre Therapeutics in Q2 2013 and held it in 1 quarter.
  • Great Point Partners's Gyre Therapeutics position peaked at $1.57M in Q2 2013.
  • 73 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2013.

Based on Great Point Partners's 13F filing for Q3 2013, filed 14 Nov 2013.